News about CIBERONC

Potential targets are identified for preventive cancer vaccines in Lynch syndrome

Research June 20 2024 2024-06-20

A new 3D model is developed to simulate the tumour microenvironment of a type of lymphoma

Researchers at the Clínic-IDIBAPS coordinated a study published in Blood Cancer Journal in which a new 3D system was developed from patient samples t1

Research March 28 2024 2024-03-28

The European THERAVLINFO project led by IDIBAPS-Hospital Clínic Barcelona is launched to advance personalised lymphoma medicine

The project led by Patricia Pérez Galán, the head of IDIBAPS’ Microenvironment in lymphoma pathogenesis and therapy research group, is the continuati1

Research October 5 2022 2022-10-05

Leukaemia’s evolution is already written right from the start, at the time of diagnosis

This discovery changes the view of the progression of leukaemia, opens the door to early diagnosis, and offers new treatment strategies.

Research February 17 2022 2022-02-18

A new treatment without chemotherapy for indolent clinical forms of mantle cell lymphoma

A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clinica1

Research April 19 2021 2021-04-19

The interaction between follicular lymphoma and its microenvironment reveals a new therapeutic strategy

Researchers from IDIBAPS and CIBERONC have analysed the interaction between follicular lymphoma and its tumour microenvironment and propose a new pro1

Research February 12 2021 2021-04-07

Sílvia Beà, winner of the CIBERONC “Award for Best Female Researcher”

Beà, a researcher of the IDIBAPS group Molecular pathology in lymphoid neoplasms, has authored 119 articles, 30 of them as the principal author, with1